Cardiovascular Therapy and Prevention, 2017, 16(6)

Clinical guidelines

COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES

Association of General (Family Care) Practitioners (Russian national registered charity). Section “Comorbidities”

Workgroup: R. G. Oganov (Co-chair) (Moscow), I. N. Denisov (Co-chair) (Moscow), V. I. Simanenkov (Coordinator) (Saint-Petersburg), Bakulin I. G. (Saint-Petersburg), Bakulina N. V. (Saint-Petersburg), Boldueva S. A. (Saint-Petersburg), Barbarash O. N. (Kemerovo), Garganeeva N. P. (Tomsk), Doshchitsin V. L. (Moscow), Drapkina O. M. (Moscow), Dudinskaya E. N. (Moscow), Kotovskaya Yu. V. (Moscow), Lila A. M. (Saint-Petersburg), Mamedov M. N. (Moscow), Mardanov B. U. (Moscow), Miller O. N. (Novosibirsk), Petrova M. M. (Krasnoyarsk), Pozdnyakov Yu. M. (Moscow),

Runikhina N. K. (Moscow), Sayganov S. A. (Saint-Petersburg), Tarasov A. V. (Moscow), Tkacheva O. N. (Moscow), Urinsky A. M. (Moscow), Shalnova S. A. (Moscow).

Key words: cardiovascular disease, cardiovascular continuum, comorbid pathology, metabolic syndrome, geriatric comorbidity, primary and secondary prevention, rational pharmacotherapy.

Cardiovascular Therapy and Prevention, 2017; 16(6): 5–56

http://dx.doi.org/10.15829/1728-8800-2017-6-5-56

Original articles

Ischemic heart disease

THE DYNAMICS OF LIFE QUALITY PARAMETERS WITH NICORANDIL USAGE IN STABLE CORONARY HEART DISEASE PATIENTS (RESULTS OF THE OBSERVATION STUDY “NIKEA”)

Martsevich S. Yu.1, Lukina Yu. V.1, Kutishenko N. P.1, Akimova А. V.1, Voronina V. P.1, Lerman О. V.1, Gaisenok О. V.2, Gomova Т. А. 3, Ezhov А. V.4, Kuimov А. D.5, Libis R. А.6, Matyushin G. V.7, Mitroshina Т. N. 8, Nechaeva G. I.9, Reznik I. I.10, Skibitsky V. V.11, Sokolova L. А.12, Chesnikova А. I.13, Dobrynina N. V.14, Yakushin S. S. 14 on behalf of the workgroup of NIKEA study*

1 National Research Center for Preventive Medicine of the Ministry of Health. Moscow; 2FSBI Joint Hospital and Polyclinics of the President Administration. Moscow; 3SHI Tulskaya Oblast Clinical Hospital. Tula; 4FSBEI HE Izhevsk State Medical Academy. Izhevsk;5FSBEI HE Novosibirsk State Medical Academy. Novosibirsk;6Orenburg State Medical University (OrSMU). Orenburg; 7V.F.Voino-Yasenetsky Krasnoyarsk State Medical University. Krasnoyarsk; 8BHI of Orlovskaya Oblast Polyclinics № 3. Orel; 9FSBEI HE Omsk State Medical University. Omsk; 10 FSBEI HE Ural State Medical University. Ekaterinburg; 11FSBEI HE Kuban State Medical University. Krasnodar; 12Federal Almazov North-West Medical Research Centre of the Ministry of Health. Saint-Petersburg; 13Rostov State Medical University of the Ministry of Health. Rostov-na-Donu; 14FSBEI HE I. P. Pavlov Ryazan State Medical University. Ryazan, Russia

Abstract

CHANGES IN THE MUCOSE OF UPPER GASTROINTESTINAL TRACT IN CORONARY HEART DISEASE

Magomedova B. M.1, Glebov К. G.2, Teplova N. V. 3, Kotovsky А. Е.1, Artamonova N. G.3

1 I.M. Sechenov First Moscow State Medical University of the Ministry of Health. Moscow; 2O. M. Filatov City Clinical Hospital №15. Moscow; 3N. I. Pirogov Russian National Research Medical University (RNRMU). Moscow, Russia

Abstract

PROGNOSIS OF ONE-DAY MORTALITY AND PROTEIN GROWTH AND DAMAGE FACTORS IN ACUTE CORONARY SYNDROME

Kayumova G. Kh.1,2, Razin V. А.2, Gimaev R. Kh. 2, Ruzov V. I.2, Arjamkina О. L.2, Gnoevykh V. V.2

1 LLC “VM Clinic”, multiprofile hospital. Ulyanovsk; 2FSEI HE Ulyanovsk State University. Ulyanovsk, Russia

Abstract

Arrhythmias

SIGNIFICANCE OF THE ALGORITHMS ON MINIMIZATION OF RIGHT-VENTRICULAR ELECTROSTIMULATION IN PREVENTION OF ATRIAL FIBRILLATION PROGRESSION IN PATIENTS WITH SICK SINUS SYNDROME

Ivanchina А. Е.1, Kopylov F. Yu.1, Samoilenko I. V.1,2, Syrkin А. L.1, Serova М. V.1

1 I.M. Sechenov First Moscow State Medical University of the Ministry of Health. Moscow; 2SBHI City Clinical Hospital № 4. Moscow, Russia

Abstract

Chronic heart failure

PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE

Drapkina О. М.1, Shepel R. N.1, Deeva Т. А. 2

1 National Research Center for Preventive Medicine of the Ministry of Health. Moscow; 2I.M. Sechenov First Moscow State Medical University of the Ministry of Health. Moscow, Russia

Abstract

GENDER DIFFERENCE AND COMORBIDITIES IN CHRONIC HEART FAILURE PATIENTS

Shukurov R. T., Abdullaev T. A.

JSC “Republic Specialized Cardiology Center”. Tashkent, Uzbekistan

Abstract

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE

Vatutin N. T.1,2, Shevelyok А. N.1,2

1 M. Gorky Donetsk National Medical University. Donetsk; 2V. K. Gusak Institute of Urgent and Reparative Surgery. Donetsk, Ukraine

Abstract

Syndrome of connective tissue dysplasia

SIGNIFICANCE OF THE FALSE CHORDS IN THE LEFT VENTRICLE FOR DIAGNOSTIC APPROACHES IN CHILD CONNECTIVE TISSUE DYSPLASIAS

Timokhina V. E.1,2, Mekhdieva К. R.1, Cherednichenko А. М.2,3, Blyakhman F. А.1,3

1 FSAEI HE Ural Federal University named after the First Russia President Eltsin B. N. of the Ministry of Education and Science. Ekaterinburg;2MAI Pediatric City Clinical Hospital № 11. Ekaterinburg; 3FSBEI HE Ural State Medical University of the Ministry of Health. Ekaterinburg, Russia

Abstract

DIAGNOSTIC SIGNIFICANCE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH PRIMARY MITRAL VALVE PROLAPSE

Yagoda A. V.1, Gladkikh N. N.1, Zangelova Т. E.2

1 FSBEI HE Stavropol State Medical University of the Ministry of Health. Stavropol; 2SBHI SK Stavropolsky Kray Clinical Hospital. Stavropol, Russia

Abstract

Treatment of cardiovascular diseases

EVALUATION OF BETA-ADRENOBLOCKERS TREATMENT IN CARDIOVASCULAR DISEASES COMORBID WITH DIABETES IN OUTPATIENT SETTING

Komkova N.А.1, Zagrebelny А.V.1, Lukina Yu.V.1, Lukyanov М. М.1, Vorobyov А. N.2, Pereverzeva К . G.2, Kutishenko N. P.1, Kiseleva N. V.1, Martsevich S. Yu.1 on behalf of the worgroups of the PROFILE* and RECVAZA** registries

1 National Research Center for Preventive Medicine of the Ministry of Health. Moscow; 2FSBEI HE I. P. Pavlov Ryazan State Medical University. Ryazan, Russia

Abstract

Epidemiology and рrevention

SMOKING AND CARDIOVASCULAR MORTALITY IN TOMSK INHABITANTS AS A TYPICAL CITY OF WESTERN SIBERIA

Efimova Е . V.1, Konobeevskaya I. N.1, Maksimenko G. V. 2, Karpov R. S.1

1 SRI of Cardiology of Tomsk National Research Medical Center. Tomsk; 2Medical Society “The Health”. Tomsk, Russia

Abstract

Opinion on a problem

CARDIOMETABOLIC DISORDERS AND UROLITHIASIS: PATHOGENESIS OF COMORBIDITY

Sharvadze G. G.1, Kerimov А. К.2, Mamedov М. N.1

1 National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia; 2SBHI City Polyclinics № 212 MHD. Moscow, Russia

Abstract

TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT

Nebieridze D. V., Kamyshova T. V., Safaryan A. S., Sargsyan V. D.

National Research Center for Preventive Medicine of the Ministry of Health. Moscow, Russia

Abstract

Reviews

THE STUDY OF LONGEVITY: RECENT UPDATES AND FURTHER DIRECTION. PART 2

Kotovskaya Yu. V.1,2, Tkacheva О. N.2, Runikhina N. К.2, Kashtanova D. А.2,3, Boytsov S. А.3

1 Peoples’ Friendship University of Russia. Moscow; 2N. I. Pirogov Russian National Research Medical University (RNRMU) — SD “Russian Gerontological Scientific-Clinical Center”. Moscow; 3National Research Center for Preventive Medicine of the Ministry of Health. Moscow; 4Russian Cardiological Research-and-Production Complex of the Ministry of Health. Moscow, Russia

Abstract

CARDIOCYTOPROTECTION PERSPECTIVES WITH ISCHEMIC PRECONDITIONING: HYPOXIA-INDUCED FACTOR 1 — POSSIBLE MOLECULAR MECHANISM AND TARGET FOR PHARMACOTHERAPY

Lyubimov A. V., Cherkashin D. V., Alanichev A. E.

FSBMEI HPE S. M. Kirov Military Medical Academy of MD RF. Saint-Petersburg, Russia

Abstract

NEW DIRECTIONS IN ATHEROSCLEROSIS PHARMACOTHERAPY

Dutova S. V., Saranchina Yu. V., Kilina O. Yu., Polshcha N. G., Kulakova T. C., Khanarin N. V.

FSBEI HE N. F. Katanov Khakassky State Medical University. Abakan, Russia

Abstract

Jubile

Rafael G. Oganov

Cardiovascular Therapy and Prevention, 2017; 16(6): 155-156

Information

Articles published in Cardiovascular Therapy and Prevention 2017

Cardiovascular Therapy and Prevention, 2017; 16(6): 160-164

Яндекс.Метрика